Robert S. Langer, Jr., Sc.D., Chairman, is David H. Koch Institute Professor at MIT. Dr. Langer is the former Chairman of the FDA Science Board, the FDA's highest advisory board. He has authored more than 1,100 scientific papers. He has approximately 800 issued and pending patents worldwide licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology, and medical device companies. Dr. Langer has received approximately 200 major awards, including the 2012 National Medal of Technology, the 2006 National Medal of Science, and the 2002 Charles Stark Draper Prize.
Bruce Lerman, MD is the H. Altschul Master Professor of Medicine, Chief of the Division of Cardiology and Director of the Electrophysiology Laboratory at Weill-Cornell and the New York Presbyterian Hospital. He received his medical degree from Loyola University - Stritch School of Medicine, was an intern and medical resident at Northwestern University and completed his cardiology fellowship at Johns Hopkins. He trained in cardiac electrophysiology at the University of Pennsylvania.
He has authored over 200 original publications, 75 book chapters and 2 books. He is a recipient of the Established Investigator Award from the American Heart Association and had received multiple grants from the NIH. He is currently on the editorial boards of Circulation, Heart Rhythm, Journal of Cardiac Electrophysiology, Pacing and Clinical Electrophysology and the Journal of Innovations in Cardiac Rhythm Management. He is a member of the the exam writing committee of the American Board of Internal Medicine for the Cardiac Electrophysiology Board Examination. Dr. Lerman served as the 2005 Chairman of the Annual Scientific Session of the American College of Cardiology (ACC) and has served on numerous committees for the American Heart Association, ACC and Heart Rhythm Society.
His research contributions include elucidating the myriad electrophsyiologic mechanisms of the nucleoside adenosine, which contributed to its FDA approval as a potent antiarrhythmic drug, pioneering the concept of current-based defibrillation and determining the role of mechanoelectrical feedback as a stimulus for triggering malignant ventricular arrhythmias. His current work focuses on the the cellular and molecular mechanisms of ventricular outflow tract tachycardia. His laboratory has identified critical somatic mutations in the cAMP signal transduction cascade that mediate this form of ventricular tachycardia, thus introducing a new paradigm for the causation of ventricular tachycardia. His work has been published in leading journnals, including Nature Genetics, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Circulation, Circulation Reseasch and The New England Journal of Medicine. He has been issued 4 patents.
He clinical concentration focuses on the diagnosis and treatment (ablation) of complex atial and ventricular arrhythmias, as well as on the treatment of life-threatening arrhythmias with implantable devices. He has served on the Scientific Advisory Boards of Biosense-Cordis Webster, Boston Scientific, Zoll Medical Corporation and Cardiovascular Therapeutics. For the last 15 years, he’s been named in New York Magazine- Best Doctors, Castle Connolly – America’s Top Doctors, US News and World Report (Best Doctors) and the New York Times (Super Doctors).